Table 2 Baseline demographics and clinical characteristics, safety population
PEG+E/placeboPlacebo/PEG+ETotal
Patients, n272451
    Aged 2–6 years18 (67%)17 (71%)35 (69%)
    Aged 7–11 years9 (33%)7 (29%)16 (31%)
Male:female ratio, n13:149:1522:29
    (%)(48%:52%)(38%:63%)(43%:57%)
Age (years)
    Mean (SD)5.3 (2.4)5.5 (2.9)5.4 (2.6)
    Range2–92–112–11
Previous laxative use, n25 (93%)22 (92%)47 (92%)